Advances in the Treatment and Management of Hodgkin Lymphoma

Researchers are hoping that an improved understanding of Hodgkin Lymphoma at the biological level will translate to new, more effective treatment options. Dr. John Sweetenham, executive medical director at the Huntsman Cancer Institute, provides an overview of developing approaches to treatment, including targeted therapies, autologous transplants and oral medications. Physician assistant John Sayler joins Dr. Sweetenham to discuss the goal of achieving long-term control of Hodgkin lymphoma, while maintaining a high quality of life for patients.

Get email alerts | http://www.patientpower.info/

Subscribe on YouTube | http://bit.ly/patientpowerYT
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower